Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1826, Issue 1, 2012, Pages 13-22

  Li, Zongwei ^a   Li, Zhuoyu ^a  

^a SHANXI UNIVERSITY   (China)

Author keywords

Cancer hallmarks; Glucose regulated protein 78; Microenvironment

Indexed keywords

CYSTEINYLTHREONYLVALYLALANYLLEUCYLPROPYLGLYCYLGLYCYLTYROSYLVALYLARGINYLVALYLCYSTEINE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR AB5 SUBTILASE; EPIGALLOCATECHIN GALLATE; GLUCOSE REGULATED PROTEIN 78; GLYCYLISOLEUCYLARGINYLLEUCYLARGINYLGLYCINE; HYBRID PROTEIN; INTERLEUKIN 24; PEPTIDE; PLASMINOGEN; PLASMINOGEN KRINGLE 5 DOMAIN PROTEIN; PYRVINIUM EMBONATE; SITIMAGENE CERADENOVEC; TAXANE DERIVATIVE; TRYPTOPHYLASPARTYLLEUCYLALANYLTRYPTOPHYLMETHIONYLPHENYLALANYLARGINYLLEUCYLPROPYLVALYLGLYCINE; TRYPTOPHYLISOLEUCYLPHENYLALANYLPROPHYLTRYPTOPHYLISOLEUCYLGLUTAMINYLLEUCINE; UNCLASSIFIED DRUG;

BREAST CANCER; BREAST TUMOR; CANCER GENE THERAPY; CANCER PROGNOSIS; CARCINOGENESIS; CELL GROWTH; CELL IMMORTALIZATION; CELL INVASION; CELL METABOLISM; CELL SURVIVAL; DRUG MECHANISM; DRUG POTENTIATION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; INFLAMMATION; METABOLIC REGULATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE TUMOR; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW; TUMOR CELL; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; CELL PROLIFERATION; GENOMICS; HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84859112544     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2012.02.001     Document Type: Review

References (154)

1. Li X., Zhang K., Li Z. Unfolded protein response in cancer: the physician's perspective. J. Hematol. Oncol. 2011, 4:8.
2. Wang M., Wey S., Zhang Y., Ye R., Lee A.S. Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid. Redox Signal. 2009, 11:2307-2316.
3. Patierno S.R., Tuscano J.M., Kim K.S., Landolph J.R., Lee A.S. Increased expression of the glucose-regulated gene encoding the Mr 78,000 glucose-regulated protein in chemically and radiation-transformed C3H 10T1/2 mouse embryo cells. Cancer Res. 1987, 47:6220-6224.
4. Lee A.S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 2007, 67:3496-3499.
5. McAllister S.S., Weinberg R.A. Tumor-host interactions: a far-reaching relationship. J. Clin. Oncol. 2010, 28:4022-4028.
6. Kaplan R.N., Psaila B., Lyden D. Niche-to-niche migration of bone-marrow-derived cells. Trends Mol. Med. 2007, 13:72-81.
7. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563.
8. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
9. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., Zhu Z., Hicklin D., Wu Y., Port J.L., Altorki N., Port E.R., Ruggero D., Shmelkov S.V., Jensen K.K., Rafii S., Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827.
10. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
11. Vermeulen L., De Sousa E.M.F., van der Heijden M., Cameron K., de Jong J.H., Borovski T., Tuynman J.B., Todaro M., Merz C., Rodermond H., Sprick M.R., Kemper K., Richel D.J., Stassi G., Medema J.P. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010, 12:468-476.
12. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989, 49:6449-6465.
13. Yauch R.L., Gould S.E., Scales S.J., Tang T., Tian H., Ahn C.P., Marshall D., Fu L., Januario T., Kallop D., Nannini-Pepe M., Kotkow K., Marsters J.C., Rubin L.L., de Sauvage F.J. A paracrine requirement for hedgehog signalling in cancer. Nature 2008, 455:406-410.
14. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
15. Ni M., Zhang Y., Lee A.S. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem. J. 2011, 434:181-188.
16. Zylicz M., King F.W., Wawrzynow A. Hsp70 interactions with the p53 tumour suppressor protein. EMBO J. 2001, 20:4634-4638.
17. Wadhwa R., Yaguchi T., Hasan M.K., Mitsui Y., Reddel R.R., Kaul S.C. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Exp. Cell Res. 2002, 274:246-253.
18. Sun Y., Yi H., Zhang P.F., Li M.Y., Li C., Li F., Peng F., Feng X.P., Yang Y.X., Yang F., Xiao Z.Q., Chen Z.C. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett. 2007, 581:131-139.
19. Arnaudeau S., Arboit P., Bischof P., Shin-ya K., Tomida A., Tsuruo T., Irion O., Cohen M. Glucose-regulated protein 78: a new partner of p53 in trophoblast. Proteomics 2009, 9:5316-5327.
20. Misra U.K., Mowery Y., Kaczowka S., Pizzo S.V. Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis. Mol. Cancer Ther. 2009, 8:1350-1362.
21. Kern J., Untergasser G., Zenzmaier C., Sarg B., Gastl G., Gunsilius E., Steurer M. GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib. Blood 2009, 114:3960-3967.
22. Carrillo-Infante C., Abbadessa G., Bagella L., Giordano A. Viral infections as a cause of cancer (review). Int. J. Oncol. 2007, 30:1521-1528.
23. Triantafilou K., Fradelizi D., Wilson K., Triantafilou M. GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. J. Virol. 2002, 76:633-643.
24. Jindadamrongwech S., Thepparit C., Smith D.R. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 2004, 149:915-927.
25. Honda T., Horie M., Daito T., Ikuta K., Tomonaga K. Molecular chaperone BiP interacts with Borna disease virus glycoprotein at the cell surface. J. Virol. 2009, 83:12622-12625.
26. Wu Y.P., Chang C.M., Hung C.Y., Tsai M.C., Schuyler S.C., Wang R.Y. Japanese encephalitis virus co-opts the ER-stress response protein GRP78 for viral infectivity. Virol. J. 2011, 8:128.
27. Pena J., Harris E. Dengue virus modulates the unfolded protein response in a time-dependent manner. J. Biol. Chem. 2011, 286:14226-14236.
28. Pasqual G., Burri D.J., Pasquato A., de la Torre J.C., Kunz S. Role of the host cell's unfolded protein response in arenavirus infection. J. Virol. 2011, 85:1662-1670.
29. Su Y.C., Wu J.L., Hong J.R. Betanodavirus up-regulates chaperone GRP78 via ER stress: roles of GRP78 in viral replication and host mitochondria-mediated cell death. Apoptosis 2011, 16:272-287.
30. Wati S., Soo M.L., Zilm P., Li P., Paton A.W., Burrell C.J., Beard M., Carr J.M. Dengue virus infection induces upregulation of GRP78, which acts to chaperone viral antigen production. J. Virol. 2009, 83:12871-12880.
31. Hsieh Y.H., Hsu J.L., Su I.J., Huang W. Genomic instability caused by hepatitis B virus: into the hepatoma inferno. Front. Biosci. 2011, 17:2586-2597.
32. Huang K.L., Lai Y.K., Lin C.C., Chang J.M. Involvement of GRP78 in inhibition of HBV secretion by Boehmeria nivea extract in human HepG2 2.2.15 cells. J. Viral Hepat. 2009, 16:367-375.
33. Cho D.Y., Yang G.H., Ryu C.J., Hong H.J. Molecular chaperone GRP78/BiP interacts with the large surface protein of hepatitis B virus in vitro and in vivo. J. Virol. 2003, 77:2784-2788.
34. McGivern D.R., Lemon S.M. Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer. Annu. Rev. Pathol. 2009, 4:399-415.
35. Takashima M., Kuramitsu Y., Yokoyama Y., Iizuka N., Toda T., Sakaida I., Okita K., Oka M., Nakamura K. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 2003, 3:2487-2493.
36. Liberman E., Fong Y.L., Selby M.J., Choo Q.L., Cousens L., Houghton M., Yen T.S. Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein. J. Virol. 1999, 73:3718-3722.
37. Harkins L., Volk A.L., Samanta M., Mikolaenko I., Britt W.J., Bland K.I., Cobbs C.S. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002, 360:1557-1563.
38. Buchkovich N.J., Maguire T.G., Paton A.W., Paton J.C., Alwine J.C. The endoplasmic reticulum chaperone BiP/GRP78 is important in the structure and function of the human cytomegalovirus assembly compartment. J. Virol. 2009, 83:11421-11428.
39. Shi-Chen Ou D., Lee S.B., Chu C.S., Chang L.H., Chung B.C., Juan L.J. Transcriptional activation of endoplasmic reticulum chaperone GRP78 by HCMV IE1-72 protein. Cell Res. 2011, 21:642-653.
40. Buchkovich N.J., Maguire T.G., Alwine J.C. Role of the endoplasmic reticulum chaperone BiP, SUN domain proteins, and dynein in altering nuclear morphology during human cytomegalovirus infection. J. Virol. 2010, 84:7005-7017.
41. Winder T., Bohanes P., Zhang W., Yang D., Power D.G., Ning Y., Gerger A., Wilson P.M., Tang L.H., Shah M., Lee A.S., Lenz H.J. GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients. Ann. Oncol. 2011, 22:2431-2439.
42. Ni M., Zhou H., Wey S., Baumeister P., Lee A.S. Regulation of PERK signaling and leukemic cell survival by a novel cytosolic isoform of the UPR regulator GRP78/BiP. PLoS One 2009, 4:e6868.
43. Thun M.J., Henley S.J., Gansler T. Inflammation and cancer: an epidemiological perspective. Novartis Found. Symp. 2004, 256:6-21. discussion 22-28, 49-52, 266-269.
44. Rosin M.P., Anwar W.A., Ward A.J. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res. 1994, 54:1929s-1933s.
45. Lu H., Ouyang W., Huang C. Inflammation, a key event in cancer development. Mol. Cancer Res. 2006, 4:221-233.
46. Mahadevan N.R., Rodvold J., Sepulveda H., Rossi S., Drew A.F., Zanetti M. Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6561-6566.
47. Quesada Calvo F., Fillet M., Renaut J., Crahay C., Gueders M., Hacha J., Paulissen G., Foidart J.M., Noel A., Rocks N., Leprince P., Cataldo D. Potential therapeutic target discovery by 2D-DIGE proteomic analysis in mouse models of asthma. J. Proteome Res. 2011, 10:4291-4301.
48. Nakajima S., Hiramatsu N., Hayakawa K., Saito Y., Kato H., Huang T., Yao J., Paton A.W., Paton J.C., Kitamura M. Selective abrogation of BiP/GRP78 blunts activation of NF-kappaB through the ATF6 branch of the UPR: involvement of C/EBPbeta and mTOR-dependent dephosphorylation of Akt. Mol. Cell. Biol. 2011, 31:1710-1718.
49. Lu M.C., Lai N.S., Yu H.C., Huang H.B., Hsieh S.C., Yu C.L. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production. Arthritis Rheum. 2010, 62:1213-1223.
50. Misra U.K., Sharma T., Pizzo S.V. Ligation of cell surface-associated glucose-regulated protein 78 by receptor-recognized forms of alpha 2-macroglobulin: activation of p21-activated protein kinase-2-dependent signaling in murine peritoneal macrophages. J. Immunol. 2005, 175:2525-2533.
51. Hori O., Matsumoto M., Kuwabara K., Maeda Y., Ueda H., Ohtsuki T., Kinoshita T., Ogawa S., Stern D.M., Kamada T. Exposure of astrocytes to hypoxia/reoxygenation enhances expression of glucose-regulated protein 78 facilitating astrocyte release of the neuroprotective cytokine interleukin 6. J. Neurochem. 1996, 66:973-979.
52. Hudson J.D., Shoaibi M.A., Maestro R., Carnero A., Hannon G.J., Beach D.H. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 1999, 190:1375-1382.
53. Vera P.L., Wang X., Bucala R.J., Meyer-Siegler K.L. Intraluminal blockade of cell-surface CD74 and glucose regulated protein 78 prevents substance P-induced bladder inflammatory changes in the rat. PLoS One 2009, 4:e5835.
54. Martins-Green M., Boudreau N., Bissell M.J. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res. 1994, 54:4334-4341.
55. Oida T., Weiner H.L. Overexpression of TGF-ss 1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF-ss. J. Immunol. 2010, 185:3529-3535.
56. Corrigall V.M., Vittecoq O., Panayi G.S. Binding immunoglobulin protein-treated peripheral blood monocyte-derived dendritic cells are refractory to maturation and induce regulatory T-cell development. Immunology 2009, 128:218-226.
57. Vollmer S., Haan C., Behrmann I. Oncostatin M up-regulates the ER chaperone Grp78/BiP in liver cells. Biochem. Pharmacol. 2010, 80:2066-2073.
58. Hao X., Yao A., Gong J., Zhu W., Li N., Li J. Berberine ameliorates pro-inflammatory cytokine-induced endoplasmic reticulum stress in human intestinal epithelial cells in vitro. Inflammation 2011, 10.1007/s10753-011-9385-6.
59. Chen Y.Y., Zheng M.Z., Lv P.P., Hu L., Wang L.L., Shen Y.L. Hydrogen peroxide regulates glucose-regulated protein 78 expression via a cyclooxygenase-2 dependent mechanism. J. Biochem. Mol. Toxicol. 2010, 24:279-285.
60. Jamora C., Dennert G., Lee A.S. Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:7690-7694.
61. Wang M., Wang P., Liu Y.Q., Peng J.L., Zhao X.P., Wu S., He F.R., Wen X., Li Y., Shen G.X. The immunosuppressive and protective ability of glucose-regulated protein 78 for improvement of alloimmunity in beta cell transplantation. Clin. Exp. Immunol. 2007, 150:546-552.
62. Cesario A., Rocca B., Rutella S. The interplay between indoleamine 2,3-dioxygenase 1 (IDO1) and cyclooxygenase (COX)-2 in chronic inflammation and cancer. Curr. Med. Chem. 2011, 18:2263-2271.
63. Oresic K., Tortorella D. Endoplasmic reticulum chaperones participate in human cytomegalovirus US2-mediated degradation of class I major histocompatibility complex molecules. J. Gen. Virol. 2008, 89:1122-1130.
64. Hockel M., Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 2001, 93:266-276.
65. Kaidi A., Williams A.C., Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 2007, 9:210-217.
66. Verras M., Papandreou I., Lim A.L., Denko N.C. Tumor hypoxia blocks Wnt processing and secretion through the induction of endoplasmic reticulum stress. Mol. Cell. Biol. 2008, 28:7212-7224.
67. Yeung B.H., Kwan B.W., He Q.Y., Lee A.S., Liu J., Wong A.S. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis. Oncogene 2008, 27:6782-6789.
68. Reddy R.K., Mao C., Baumeister P., Austin R.C., Kaufman R.J., Lee A.S. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J. Biol. Chem. 2003, 278:20915-20924.
69. Zhou H., Zhang Y., Fu Y., Chan L., Lee A.S. Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK). J. Biol. Chem. 2011, 286:25687-25696.
70. Shu C.W., Sun F.C., Cho J.H., Lin C.C., Liu P.F., Chen P.Y., Chang M.D., Fu H.W., Lai Y.K. GRP78 and Raf-1 cooperatively confer resistance to endoplasmic reticulum stress-induced apoptosis. J. Cell. Physiol. 2008, 215:627-635.
71. Lin Y., Wang Z., Liu L., Chen L. Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells. Lung Cancer 2011, 71:291-297.
72. Misra U.K., Gonzalez-Gronow M., Gawdi G., Hart J.P., Johnson C.E., Pizzo S.V. The role of Grp 78 in alpha 2-macroglobulin-induced signal transduction. Evidence from RNA interference that the low density lipoprotein receptor-related protein is associated with, but not necessary for, GRP 78-mediated signal transduction. J. Biol. Chem. 2002, 277:42082-42087.
73. Misra U.K., Deedwania R., Pizzo S.V. Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J. Biol. Chem. 2006, 281:13694-13707.
74. Misra U.K., Wang F., Pizzo S.V. Transcription factor TFII-I causes transcriptional upregulation of GRP78 synthesis in prostate cancer cells. J. Cell. Biochem. 2009, 106:381-389.
75. Misra U.K., Payne S., Pizzo S.V. Ligation of prostate cancer cell surface GRP78 activates a proproliferative and antiapoptotic feedback loop: a role for secreted prostate-specific antigen. J. Biol. Chem. 2011, 286:1248-1259.
76. Kelber J.A., Panopoulos A.D., Shani G., Booker E.C., Belmonte J.C., Vale W.W., Gray P.C. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene 2009, 28:2324-2336.
77. Shani G., Fischer W.H., Justice N.J., Kelber J.A., Vale W., Gray P.C. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth. Mol. Cell. Biol. 2008, 28:666-677.
78. Gonzalez-Gronow M., Cuchacovich M., Llanos C., Urzua C., Gawdi G., Pizzo S.V. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum. Cancer Res. 2006, 66:11424-11431.
79. Selim M.A., Burchette J.L., Bowers E.V., de Ridder G.G., Mo L., Pizzo S.V., Gonzalez-Gronow M. Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival. Melanoma Res. 2011, 21:323-334.
80. de Ridder G.G., Gonzalez-Gronow M., Ray R., Pizzo S.V. Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanoma. Melanoma Res. 2011, 21:35-43.
81. Dong D., Ko B., Baumeister P., Swenson S., Costa F., Markland F., Stiles C., Patterson J.B., Bates S.E., Lee A.S. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res. 2005, 65:5785-5791.
82. Hsu J.L., Chiang P.C., Guh J.H. Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78. Naunyn Schmiedebergs Arch. Pharmacol. 2009, 380:373-382.
83. Gosky D., Chatterjee S. Down-regulation of topoisomerase II alpha is caused by up-regulation of GRP78. Biochem. Biophys. Res. Commun. 2003, 300:327-332.
84. Wang Y., Wang W., Wang S., Wang J., Shao S., Wang Q. Down-regulation of GRP78 is associated with the sensitivity of chemotherapy to VP-16 in small cell lung cancer NCI-H446 cells. BMC Cancer 2008, 8:372.
85. Mhaidat N.M., Alali F.Q., Matalqah S.M., Matalka I.I., Jaradat S.A., Al-Sawalha N.A., Thorne R.F. Inhibition of MEK sensitizes paclitaxel-induced apoptosis of human colorectal cancer cells by downregulation of GRP78. Anticancer Drugs 2009, 20:601-606.
86. Venkataramani V., Rossner C., Iffland L., Schweyer S., Tamboli I.Y., Walter J., Wirths O., Bayer T.A. Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the Alzheimer amyloid precursor protein. J. Biol. Chem. 2010, 285:10678-10689.
87. Baumeister P., Dong D., Fu Y., Lee A.S. Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis. Mol. Cancer Ther. 2009, 8:1086-1094.
88. Fu Y., Li J., Lee A.S. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 2007, 67:3734-3740.
89. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124:269-270.
90. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
91. Semenza G.L., Artemov D., Bedi A., Bhujwalla Z., Chiles K., Feldser D., Laughner E., Ravi R., Simons J., Taghavi P., Zhong H. 'The metabolism of tumours': 70years later. Novartis Found. Symp. 2001, 240:251-260. discussion 260-254.
92. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
93. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
94. Yeung S.J., Pan J., Lee M.H. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell. Mol. Life Sci. 2008, 65:3981-3999.
95. Gordan J.D., Thompson C.B., Simon M.C. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007, 12:108-113.
96. Zhang L.H., Yang X.L., Zhang X., Cheng J.X., Zhang W. Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways. Brain Res. 2011, 1371:23-31.
97. Fu Y., Wey S., Wang M., Ye R., Liao C.P., Roy-Burman P., Lee A.S. Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19444-19449.
98. Wey S., Luo B., Tseng C.C., Ni M., Zhou H., Fu Y., Bhojwani D., Carroll W.L., Lee A.S. Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling. Blood 2012, 119:817-825.
99. Dai R.Y., Chen S.K., Yan D.M., Chen R., Lui Y.P., Duan C.Y., Li J., He T., Li H. PI3K/Akt promotes GRP78 accumulation and inhibits endoplasmic reticulum stress-induced apoptosis in HEK293 cells. Folia Biol. (Praha) 2010, 56:37-46.
100. Miharada K., Karlsson G., Rehn M., Rorby E., Siva K., Cammenga J., Karlsson S. Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor through cell surface receptor GRP78. Cell Stem Cell 2011, 9:330-344.
101. Sawada N., Yao J., Hiramatsu N., Hayakawa K., Araki I., Takeda M., Kitamura M. Involvement of hypoxia-triggered endoplasmic reticulum stress in outlet obstruction-induced apoptosis in the urinary bladder. Lab. Invest. 2008, 88:553-563.
102. Vousden K.H. Alternative fuel-another role for p53 in the regulation of metabolism. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7117-7118.
103. Vousden K.H., Ryan K.M. p53 and metabolism. Nat. Rev. Cancer 2009, 9:691-700.
104. Bensaad K., Vousden K.H. p53: new roles in metabolism. Trends Cell Biol. 2007, 17:286-291.
105. Dong D., Ni M., Li J., Xiong S., Ye W., Virrey J.J., Mao C., Ye R., Wang M., Pen L., Dubeau L., Groshen S., Hofman F.M., Lee A.S. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res. 2008, 68:498-505.
106. Dong D., Stapleton C., Luo B., Xiong S., Ye W., Zhang Y., Jhaveri N., Zhu G., Ye R., Liu Z., Bruhn K.W., Craft N., Groshen S., Hofman F.M., Lee A.S. A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res. 2011, 71:2848-2857.
107. Katanasaka Y., Ishii T., Asai T., Naitou H., Maeda N., Koizumi F., Miyagawa S., Ohashi N., Oku N. Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78. Int. J. Cancer 2010, 127:2685-2698.
108. Virrey J.J., Dong D., Stiles C., Patterson J.B., Pen L., Ni M., Schonthal A.H., Chen T.C., Hofman F.M., Lee A.S. Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells. Mol. Cancer Res. 2008, 6:1268-1275.
109. Fu Y., Lee A.S. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy. Cancer Biol. Ther. 2006, 5:741-744.
110. Chiu C.C., Lin C.Y., Lee L.Y., Chen Y.J., Kuo T.F., Chang J.T., Liao C.T., Wang H.M., Yen T.C., Shen C.R., Liao S.K., Cheng A.J. Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention. Mol. Cancer Ther. 2008, 7:2788-2797.
111. Su R., Li Z., Li H., Song H., Bao C., Wei J., Cheng L. Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer 2010, 10:20.
112. Misra U.K., Deedwania R., Pizzo S.V. Binding of activated alpha2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK. J. Biol. Chem. 2005, 280:26278-26286.
113. Davidson D.J., Haskell C., Majest S., Kherzai A., Egan D.A., Walter K.A., Schneider A., Gubbins E.F., Solomon L., Chen Z., Lesniewski R., Henkin J. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer Res. 2005, 65:4663-4672.
114. Gonzalez-Gronow M., Kaczowka S.J., Payne S., Wang F., Gawdi G., Pizzo S.V. Plasminogen structural domains exhibit different functions when associated with cell surface GRP78 or the voltage-dependent anion channel. J. Biol. Chem. 2007, 282:32811-32820.
115. McFarland B.C., Stewart J., Hamza A., Nordal R., Davidson D.J., Henkin J., Gladson C.L. Plasminogen kringle 5 induces apoptosis of brain microvessel endothelial cells: sensitization by radiation and requirement for GRP78 and LRP1. Cancer Res. 2009, 69:5537-5545.
116. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
117. Dimri G.P. What has senescence got to do with cancer?. Cancer Cell 2005, 7:505-512.
118. Alcorta D.A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J.C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:13742-13747.
119. Dickson M.A., Hahn W.C., Ino Y., Ronfard V., Wu J.Y., Weinberg R.A., Louis D.N., Li F.P., Rheinwald J.G. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 2000, 20:1436-1447.
120. Beausejour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 2003, 22:4212-4222.
121. Salway K.D., Gallagher E.J., Page M.M., Stuart J.A. Higher levels of heat shock proteins in longer-lived mammals and birds. Mech. Ageing Dev. 2011, 132:287-297.
122. Pfaffenbach K.T., Lee A.S. The critical role of GRP78 in physiologic and pathologic stress. Curr. Opin. Cell Biol. 2011, 23:150-156.
123. Qian Y., Zheng Y., Ramos K.S., Tiffany-Castiglioni E. GRP78 compartmentalized redistribution in Pb-treated glia: role of GRP78 in lead-induced oxidative stress. Neurotoxicology 2005, 26:267-275.
124. 2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen species. Mol. Cancer Ther. 2010, 9:1378-1395.
125. Chung Y.M., Lee S.B., Kim H.J., Park S.H., Kim J.J., Chung J.S., Yoo Y.D. Replicative senescence induced by Romo1-derived reactive oxygen species. J. Biol. Chem. 2008, 283:33763-33771.
126. Ho J.H., Chen Y.F., Ma W.H., Tseng T.C., Chen M.H., Lee O.K. Cell contact accelerates replicative senescence of human mesenchymal stem cells independent of telomere shortening and p53 activation: roles of Ras and oxidative stress. Cell Transplant. 2011, 20:1209-1220.
127. Collado M., Blasco M.A., Serrano M. Cellular senescence in cancer and aging. Cell 2007, 130:223-233.
128. Ermakova S.P., Kang B.S., Choi B.Y., Choi H.S., Schuster T.F., Ma W.Y., Bode A.M., Dong Z. (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res. 2006, 66:9260-9269.
129. Li M., Wang J., Jing J., Hua H., Luo T., Xu L., Wang R., Liu D., Jiang Y. Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70. J. Cell. Mol. Med. 2009, 13:4540-4550.
130. Paton A.W., Beddoe T., Thorpe C.M., Whisstock J.C., Wilce M.C., Rossjohn J., Talbot U.M., Paton J.C. AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 2006, 443:548-552.
131. Backer J.M., Krivoshein A.V., Hamby C.V., Pizzonia J., Gilbert K.S., Ray Y.S., Brand H., Paton A.W., Paton J.C., Backer M.V. Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells. Neoplasia 2009, 11:1165-1173.
132. Gupta P., Walter M.R., Su Z.Z., Lebedeva I.V., Emdad L., Randolph A., Valerie K., Sarkar D., Fisher P.B. BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res. 2006, 66:8182-8191.
133. Yu D.H., Macdonald J., Liu G., Lee A.S., Ly M., Davis T., Ke N., Zhou D., Wong-Staal F., Li Q.X. Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapy. PLoS One 2008, 3:e3951.
134. Zhang Y., Liu R., Ni M., Gill P., Lee A.S. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J. Biol. Chem. 2010, 285:15065-15075.
135. Weidle U.H., Maisel D., Klostermann S., Schiller C., Weiss E.H. Intracellular proteins displayed on the surface of tumor cells as targets for therapeutic intervention with antibody-related agents. Cancer Genomics Proteomics 2011, 8:49-63.
136. Misra U.K., Pizzo S.V. Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells. Cancer Biol. Ther. 2010, 9:142-152.
137. Misra U.K., Pizzo S.V. Modulation of the unfolded protein response in prostate cancer cells by antibody-directed against the carboxyl-terminal domain of GRP78. Apoptosis 2010, 15:173-182.
138. Kim Y., Lillo A.M., Steiniger S.C., Liu Y., Ballatore C., Anichini A., Mortarini R., Kaufmann G.F., Zhou B., Felding-Habermann B., Janda K.D. Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand. Biochemistry 2006, 45:9434-9444.
139. Yoneda Y., Steiniger S.C., Capkova K., Mee J.M., Liu Y., Kaufmann G.F., Janda K.D. A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy. Bioorg. Med. Chem. Lett. 2008, 18:1632-1636.
140. Arap M.A., Lahdenranta J., Mintz P.J., Hajitou A., Sarkis A.S., Arap W., Pasqualini R. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 2004, 6:275-284.
141. Passarella R.J., Spratt D.E., van der Ende A.E., Phillips J.G., Wu H., Sathiyakumar V., Zhou L., Hallahan D.E., Harth E., Diaz R. Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors. Cancer Res. 2010, 70:4550-4559.
142. Larson N., Ray A., Malugin A., Pike D.B., Ghandehari H. HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer. Pharm. Res. 2010, 27:2683-2693.
143. Uckun F.M., Qazi S., Ozer Z., Garner A.L., Pitt J., Ma H., Janda K.D. Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network. Br. J. Haematol. 2011, 153:741-752.
144. Dong D., Dubeau L., Bading J., Nguyen K., Luna M., Yu H., Gazit-Bornstein G., Gordon E.M., Gomer C., Hall F.L., Gambhir S.S., Lee A.S. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Hum. Gene Ther. 2004, 15:553-561.
145. Gazit G., Hung G., Chen X., Anderson W.F., Lee A.S. Use of the glucose starvation-inducible glucose-regulated protein 78 promoter in suicide gene therapy of murine fibrosarcoma. Cancer Res. 1999, 59:3100-3106.
146. Chen X., Zhang D., Dennert G., Hung G., Lee A.S. Eradication of murine mammary adenocarcinoma through HSVtk expression directed by the glucose-starvation inducible grp78 promoter. Breast Cancer Res. Treat. 2000, 59:81-90.
147. Azatian A., Yu H., Dai W., Schneiders F.I., Botelho N.K., Lord R.V. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas. J. Gastrointest. Surg. 2009, 13:1044-1051.
148. Pootrakul L., Datar R.H., Shi S.R., Cai J., Hawes D., Groshen S.G., Lee A.S., Cote R.J. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer. Clin. Cancer Res. 2006, 12:5987-5993.
149. Zheng H.C., Takahashi H., Li X.H., Hara T., Masuda S., Guan Y.F., Takano Y. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum. Pathol. 2008, 39:1042-1049.
150. Lee E., Nichols P., Groshen S., Spicer D., Lee A.S. GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy. Int. J. Cancer 2011, 128:726-731.
151. Lee E., Nichols P., Spicer D., Groshen S., Yu M.C., Lee A.S. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res. 2006, 66:7849-7853.
152. Mintz P.J., Kim J., Do K.A., Wang X., Zinner R.G., Cristofanilli M., Arap M.A., Hong W.K., Troncoso P., Logothetis C.J., Pasqualini R., Arap W. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat. Biotechnol. 2003, 21:57-63.
153. Defresne F., Bouzin C., Guilbaud C., Dieu M., Delaive E., Michiels C., Raes M., Feron O. Differential influence of anticancer treatments and angiogenesis on the seric titer of autoantibody used as tumor and metastasis biomarker. Neoplasia 2010, 12:562-570.
154. Tsunemi S., Nakanishi T., Fujita Y., Bouras G., Miyamoto Y., Miyamoto A., Nomura E., Takubo T., Tanigawa N. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer. Oncol. Rep. 2010, 23:949-956.